blinatumomab

Ligand id: 7384

Name: blinatumomab

Immunopharmacology Comments
Blinatumomab is an immuno-oncology agent.
Immunopharmacology Disease
Disease X-Refs Comment References
Acute lymphocytic leukemia (ALL) OMIM: 613065
Approved specifically for Philadelphia chromosome-negative precursor B-cell acute lymphoblastic leukemia (B-cell ALL), an uncommon form of ALL.